hansoh glp-1 Regeneron/Hansoh's GLP-1/GIPr agonist shows 19% weight loss in China Phase III Hansoh Pharma licenses dual incretin

lucidum polysaccharides and triterpenoids mitigate cardiac aging by activating the Nrf2/HO-1 and SOD2 antioxidant pathways, thereby enhancing cellular defense and mitochondrial stability ( H

Cells (5 10 5 cells/well) were seeded in 6-well plates and cultured in control condition and exposed to 0.4 mM L-cysteine and/or 0.1 mM cobalt chloride and were collected at 16 h after stimulation

Importantly, this study also showed that this results in muscle glycogen sparing during low-intensity exercise (consistent with an increase in fat oxidation) and lower lactate accumulation during high-intensity exercise

Incidence of health insurance claims for thyroid neoplasm and pancreatic malignancy in association with exenatide: signal refinement using active safety surveillance